blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0566226

EP0566226 - Quinazoline derivatives [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.09.1996
Database last updated on 27.07.2024
Most recent event   Tooltip13.09.1996No opposition filed within time limitpublished on 30.10.1996 [1996/44]
Applicant(s)For all designated states
Zeneca Limited
15 Stanhope Gate
London W1Y 6LN / GB
[N/P]
Former [1995/28]For all designated states
ZENECA LIMITED
15 Stanhope Gate
London W1Y 6LN / GB
Former [1993/42]For all designated states
Zeneca Limited
15 Stanhope Gate
London W1Y 6LN / GB
Inventor(s)01 / Barker, Andrew John, Zeneca Pharmaceuticals
Mereside, Alderley Park
Macclesfield, Cheshire, SK10 4TG / GB
[1993/42]
Representative(s)Tait, Brian Steele, et al
Intellectual Property Department ZENECA Pharmaceuticals Mereside Alderley Park
Macclesfield Cheshire SK10 4TG / GB
[N/P]
Former [1995/45]Tait, Brian Steele, et al
Intellectual Property Department ZENECA Pharmaceuticals Mereside Alderley Park
Macclesfield Cheshire SK10 4TG / GB
Former [1993/42]Tait, Brian Steele
ICI Group Patents Service Dept. PO Box 6 Shire Park Bessemer Road
Welwyn Garden City Herts AL7 1HD / GB
Application number, filing date93300270.115.01.1993
[1993/42]
Priority number, dateGB1992000109520.01.1992         Original published format: GB 9201095
GB1992001357226.06.1992         Original published format: GB 9213572
GB1992002373512.11.1992         Original published format: GB 9223735
[1993/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0566226
Date:20.10.1993
Language:EN
[1993/42]
Type: B1 Patent specification 
No.:EP0566226
Date:08.11.1995
Language:EN
[1995/45]
Search report(s)(Supplementary) European search report - dispatched on:EP30.03.1993
ClassificationIPC:C07D239/94, C07D491/056, // C07D403/12, A61K31/505 ,(C07D491/056, 319:00, 239:00),(C07D491/056, 317:00, 239:00)
[1993/42]
CPC:
C07D403/04 (EP,US); A61P35/00 (EP); C07D239/94 (EP,US);
C07D491/04 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1993/42]
TitleGerman:Chinazolinderivate[1993/42]
English:Quinazoline derivatives[1993/42]
French:Dérivés de quinazoline[1993/42]
Examination procedure25.11.1993Examination requested  [1994/03]
21.02.1994Despatch of a communication from the examining division (Time limit: M06)
26.08.1994Reply to a communication from the examining division
16.09.1994Despatch of a communication from the examining division (Time limit: M04)
15.11.1994Reply to a communication from the examining division
09.01.1995Despatch of communication of intention to grant (Approval: Yes)
10.05.1995Communication of intention to grant the patent
22.05.1995Fee for grant paid
22.05.1995Fee for publishing/printing paid
Opposition(s)09.08.1996No opposition filed within time limit [1996/44]
Fees paidRenewal fee
16.12.1994Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US3985749  (FOSTER CHARLES H);
 [AD]GB2033894  (SANKYO CO, et al);
 [A]GB2160201  (WYETH JOHN & BROTHER LTD);
 [YP]WO9214716  (PFIZER [US]);
 [YP]EP0520722  (ICI PLC [GB])
 [X]  - CHEMICAL ABSTRACTS, vol. 51, 1957, Columbus, Ohio, US; abstract no. 9625D,9625G, 'Studies in potential amebicides' column 9625 ;
 [AD]  - CHEMICAL ABSTRACTS, vol. 70, 1969, Columbus, Ohio, US; abstract no. 68419U, 'Hypotensive and bronchodilatory quinolines, isoquinolines and quinazolines' page 397 ;
 [A]  - CHEMICAL ABSTRACTS, vol. 80, 1974, Columbus, Ohio, US; abstract no. 70768G, 'synthesis of certain nitroquinazoline derivatives structurally related to some chemotherapeutic agents' page 343 ;
 [XD]  - CHEMICAL ABSTRACTS, vol. 92, 1980, Columbus, Ohio, US; abstract no. 76445U, 'Synthesis of shangrolin analogs as antimalerial agents' page 674 ;
 [X]  - CHEMICAL ABSTRACTS, vol. 96, 1982, Columbus, Ohio, US; abstract no. 122728W, 'Studies on antiarrhythmics' page 695 ;
 [AD]  - DRUGS OF THE FUTURE vol. 17, no. 2, 1992, pages 119 - 131; 'protein-tyrosine kinase inhibitors'
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.